These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 1493908
1. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia. Dubosc-Marchenay N, Lacombe F, Dumain P, Marit G, Montastruc M, Belloc F, Reiffers J. Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908 [Abstract] [Full Text] [Related]
2. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F, Chen Y. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [Abstract] [Full Text] [Related]
3. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients]. Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL. Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213 [Abstract] [Full Text] [Related]
4. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894 [Abstract] [Full Text] [Related]
5. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, Falkenrodt A, Lecalvez G, Maynadié M, Béné MC. Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939 [Abstract] [Full Text] [Related]
6. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype. Mesárosová A, Hrivnáková A, Babusíková O. Neoplasma; 1993 Mar; 40(6):341-5. PubMed ID: 8289964 [Abstract] [Full Text] [Related]
9. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL). Solary E, Casasnovas RO, Campos L, Béné MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N. Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696 [Abstract] [Full Text] [Related]
10. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]. Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ. Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262 [Abstract] [Full Text] [Related]
11. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital. Ghosh S, Shinde SC, Kumaran GS, Sapre RS, Dhond SR, Badrinath Y, Ansari R, Kumar A, Mahadik S, Chougule AB, Nair CN. Indian J Cancer; 2003 Nov; 40(2):71-6. PubMed ID: 14716122 [Abstract] [Full Text] [Related]
12. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M. Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721 [Abstract] [Full Text] [Related]
13. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G. Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393 [Abstract] [Full Text] [Related]
14. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia. Lanza F, Rigolin GM, Moretti S, Latorraca A, Castoldi G. Leuk Lymphoma; 1994 Mar; 13 Suppl 1():81-5. PubMed ID: 7521238 [Abstract] [Full Text] [Related]
15. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler H, Riehm H, Schellong G, Ludwig WD. Blood; 1995 Oct 15; 86(8):3097-108. PubMed ID: 7579404 [Abstract] [Full Text] [Related]
16. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis. Klobusicka M, Kusenda J, Babusikova O. Neoplasma; 2005 Oct 15; 52(3):211-8. PubMed ID: 15875082 [Abstract] [Full Text] [Related]
17. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia]. Gu LJ, Tie LJ, Jiang LM, Chen J, Pan C, Dong L, Chen J, Xue HL, Tang JY, Wang YP, Ye H. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr 15; 11(4):241-5. PubMed ID: 19374802 [Abstract] [Full Text] [Related]
18. Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Marosi C, Köller U, Koller-Weber E, Schwarzinger I, Schneider B, Jäger U, Vahls P, Nowotny H, Pirc-Danoewinata H, Steger G. Cancer Genet Cytogenet; 1992 Jul 01; 61(1):14-25. PubMed ID: 1638477 [Abstract] [Full Text] [Related]
19. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X. Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638 [Abstract] [Full Text] [Related]
20. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases. Dunphy CH, Tang W. Arch Pathol Lab Med; 2007 May 01; 131(5):748-54. PubMed ID: 17488160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]